Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb 23:14:1774782.
doi: 10.3389/fbioe.2026.1774782. eCollection 2026.

Rapid and reagent-free screening of occult hepatitis B virus infection based on plasma Vis-NIR spectral pattern recognition

Affiliations

Rapid and reagent-free screening of occult hepatitis B virus infection based on plasma Vis-NIR spectral pattern recognition

Linbin Huang et al. Front Bioeng Biotechnol. .

Abstract

Introduction: Occult hepatitis B virus infection (OBI) is a specific form of hepatitis B virus (HBV) infection characterized by testing negative for Hepatitis B surface antigen (HBsAg) with the presence of HBV DNA in the blood. Due to the complexity and high cost of HBV DNA testing, which is rarely included in routine physical examinations, leading to underdiagnosis of OBI. In this study, plasma visible-near-infrared (Vis-NIR) spectroscopy pattern recognition was employed to develop the discriminant analysis models for distinguishing between OBI from healthy (normal controls) plasma.

Methods: A total of 444 plasma samples from voluntary blood donors (OBI 204, normal controls 240) were collected, and their Vis-NIR spectra were measured. The samples were rigorously divided into training, prediction, and independent external validation sets. Partial least squares-discriminant analysis (PLS-DA) and k-nearest neighbor (kNN) were used as spectral classifiers; standard normal variate (SNV) and norris derivative filtering (NDF) were applied for spectral preprocessing. The integrated algorithm combining separation degree priority combination (SDPC) with wavelength step-by-step phase-out (WSP) was utilized for the optimal wavelength selection.

Results: The plasma spectral discriminant models for OBI and normal control were successfully established. Based on the optimal SNV-NDF preprocessed spectra, the SDPC-WSP-kNN and SDPC-WSP-PLS-DA methods determined the optimal number of wavelengths N to be 5 and 26, respectively. When evaluated on the independent external validation set, the SDPC-WSP-kNN model demonstrated better robustness, achieving sensitivity, specificity, and total recognition accuracy rates of 96.6%, 100%, and 98.7%, respectively. By introducing a grey judgment zone, both SEN and SPE reached 100%, with a detection recovery rate of 96.8%.

Conclusion: These results indicated that Vis-NIR spectroscopy pattern recognition can accurately discriminate between OBI and normal controls' plasma samples. This method is reagent-free, rapid, and simple, making it suitable for large-scale, low-cost rapid screening of OBI. In particular, the proposed few-wavelength model can provide an important reference for the development of small specialized blood analyzers for OBI detection.

Keywords: blood screening; multi-wavelength; norris derivative filtering; occult hepatitis B virus infection; partial least squares-discriminant analysis; separation degree priority combination; step-by-step phase-out; visible-near-infrared spectralpattern recognition.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Vis-NIR spectra of all OBI and normal control plasma samples: (a) Raw spectra; (b) SNV-NDF combination preprocessing spectra (d = 2, s = 21, g = 2); (c) SNV-NDF combination preprocessing spectra (d = 2, s = 3, g = 3).
FIGURE 2
FIGURE 2
Separation degree spectrum of the two spectral populations after preprocessing in modeling: (a) 333–1118 nm (d = 2, s = 21, g = 2); (b) Selected waveband combination of the optimal SDPC-PLS-DA model (d = 2, s = 21, g = 2); (c) 333–1118 nm (d = 2, s = 3, g = 3); (d) Selected waveband combination of the optimal SDPC-kNN model (d = 2, s = 3, g = 3).
FIGURE 3
FIGURE 3
Preprocessed absorbance at a wavelength in order from smallest to largest for two types of modeling spectra: (a) 592 nm (d = 2, s = 21, g = 2); (b) 584 nm (d = 2, s = 3, g = 3).
FIGURE 4
FIGURE 4
External validation results of the SDPC-WSP-PLS-DA model with SNV-NDF preprocessing: (a) Prediction value of class variable for OBI and normal control; (b) Schematic diagram of discrimination after introducing the gray area (G, 4.6 < S < 5.2).
FIGURE 5
FIGURE 5
Prediction class variable labels in the SDPC-WSP-kNN model with SNV-NDF preprocessing.

References

    1. Alshrari A. S., Hudu S. A., Shinkafi S. H., Tahir A., Raji H. Y., Jimoh A. O. (2025). Prevalence and transfusion risks of occult hepatitis B infection among HBcAb-Positive blood donors in a high-endemic region. Diagn. (Basel) 15 (4), 486. 10.3390/diagnostics15040486 - DOI - PMC - PubMed
    1. Barnes Msd R. J., Lister S. J. (1989). Standard normal variate transformation and De-trending of near-infrared diffuse reflectance spectr. Appl. Spectrosc. 43, 772–777. 10.1366/0003702894202201 - DOI
    1. Candotti D., Assennato S. M., Laperche S., Allain J. P., Levicnik-Stezinar S. (2019). Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose. Gut 68 (2), 313–321. 10.1136/gutjnl-2018-316490 - DOI - PubMed
    1. Chen J., Ma J., Han X., Zhou Y., Xie B., Huang F., et al. (2023). Rapid detection of hepatitis B virus DNA level based on interval-point data fusion of infrared spectra. J. Biophot. 16 (3), e202200251. 10.1002/jbio.202200251 - DOI - PubMed
    1. Chi K., Lin J., Chen M., Chen J., Chen Y., Pan T. (2024). Changeable moving window-standard normal variable transformation for visible-NIR spectroscopic analyses. Spectrochim. Acta A Mol. Biomol. Spectrosc. 308, 123726. 10.1016/j.saa.2023.123726 - DOI - PubMed

LinkOut - more resources